We are live on ! Find out more
PALI icon

Palisade Bio
PALI

11 hedge funds and large institutions have $648K invested in Palisade Bio in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 0 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.52% more ownership

Funds ownership: 0.02% → 0.54% (+0.52%)

23% less capital invested

Capital invested by funds: $842K → $648K (-$194K)

58% less funds holding

Funds holding: 26 → 11 (-15)

88% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 17

Holders
11
Holders Change
-15
Holders Change %
-57.69%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
–
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
+$155K
2
WAM
Warberg Asset Management
Illinois
+$90.1K
3
VF
Virtu Financial
New York
+$70.6K
4
TSS
Two Sigma Securities
New York
+$69.8K
5
Two Sigma Investments
Two Sigma Investments
New York
+$34K

Top Sellers

Rank Fund Capital Flow
1
ACM
Altium Capital Management
New York
-$559K
2
SIG
Sargent Investment Group
Maryland
-$76K
3
Renaissance Technologies
Renaissance Technologies
New York
-$51K
4
SM
Sabby Management
Florida
-$44K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$208K +$155K +2,667 New
WAM
2
Warberg Asset Management
Illinois
$137K +$90.1K +1,554 +777%
VF
3
Virtu Financial
New York
$106K +$70.6K +1,218 +834%
TSS
4
Two Sigma Securities
New York
$102K +$69.8K +1,204 +1,105%
Two Sigma Investments
5
Two Sigma Investments
New York
$54.1K +$34K +586 +548%
UBS Group
6
UBS Group
Switzerland
$21.4K +$8.12K +140 +104%
Morgan Stanley
7
Morgan Stanley
New York
$11.5K +$3.42K +59 +67%
JP Morgan Chase
8
JP Morgan Chase
New York
$6K +$4.29K +74 New
Wells Fargo
9
Wells Fargo
California
$1.74K – – –
BlackRock
10
BlackRock
New York
$42 – – –
Northwestern Mutual Wealth Management
11
Northwestern Mutual Wealth Management
Wisconsin
$5 – – –
ACM
12
Altium Capital Management
New York
– -$559K -7,524 Closed
SIG
13
Sargent Investment Group
Maryland
– -$76K -893 Closed
Renaissance Technologies
14
Renaissance Technologies
New York
– -$51K -683 Closed
SM
15
Sabby Management
Florida
– -$44K -595 Closed
Geode Capital Management
16
Geode Capital Management
Massachusetts
– -$12K -173 Closed
Vanguard Group
17
Vanguard Group
Pennsylvania
– -$8K -103 Closed
Millennium Management
18
Millennium Management
New York
– -$7K -91 Closed
BSW
19
Buckingham Strategic Wealth
Missouri
– -$5K -61 Closed
PAG
20
Private Advisor Group
New Jersey
– -$3K -45 Closed
Citadel Advisors
21
Citadel Advisors
Florida
– -$3K -38 Closed
State Street
22
State Street
Massachusetts
– -$3K -38 Closed
Northern Trust
23
Northern Trust
Illinois
– -$2K -31 Closed
CAN
24
Cetera Advisor Networks
California
– -$2K -29 Closed
Fidelity Investments
25
Fidelity Investments
Massachusetts
– -$2K -27 Closed
1
2

PALI Hedge Fund Activity: Q4 2022 in Review

11 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Palisade Bio (PALI) for Q4 2022, worth a combined $648K — down 23% from $842K a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of PALI and 2 opened new positions — a net loss of 15 holders — while 0 trimmed existing stakes and 6 added.

The largest buyer was CVI Holdings, opening a new position worth an estimated $155K. The largest seller was Altium Capital Management, exiting entirely with an estimated $559K sold.

  • 11 institutional investors held Palisade Bio (PALI) as of Q4 2022, down from 26 in Q3 2022.
  • Funds reported $648K of Palisade Bio stock for Q4 2022, down 23% quarter-over-quarter.
  • 2 funds opened new Palisade Bio positions in Q4 2022 and 17 closed out, a net change of -15 holders.
  • The largest Palisade Bio buyer in Q4 2022 was CVI Holdings, an estimated $155K added.
  • The largest Palisade Bio seller in Q4 2022 was Altium Capital Management, an estimated $559K sold.

Based on aggregated 13F filings for Q4 2022.